![Bill Colone](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Bill Colone
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Singlepass, Inc.
![]() Singlepass, Inc. Medical SpecialtiesHealth Technology Singlepass, Inc. has developed a unique electrocautery device that improves the clinical outcomes of deep tissue biopsy procedures. The company is based in Lake Forest, CA. The patented, single-use device prevents and stops bleeding caused by tissue extraction by cauterizing the tissue channel. It is the only cautery device of its kind that can be used for biopsy procedures. Singlepass was founded by Peter Sunenshine and Kevin Hirsch. The CEO is Bill Colone. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Bill Colone
Ehemalige bekannte Positionen von Bill Colone
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
UroDev Medical
![]() UroDev Medical Medical SpecialtiesHealth Technology UroDev Medical develops a urinary catheter that allows the patient to control the flow of urine by actuating a magnetic valve. The company was founded by Zach Mckinney and Derek Herrera in 2015 and is headquartered in San Clemente, CA. | Vorstandsvorsitzender | - | - |
Statistik
International
Vereinigte Staaten | 3 |
Operativ
Chief Executive Officer | 2 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
UroDev Medical
![]() UroDev Medical Medical SpecialtiesHealth Technology UroDev Medical develops a urinary catheter that allows the patient to control the flow of urine by actuating a magnetic valve. The company was founded by Zach Mckinney and Derek Herrera in 2015 and is headquartered in San Clemente, CA. | Health Technology |
Singlepass, Inc.
![]() Singlepass, Inc. Medical SpecialtiesHealth Technology Singlepass, Inc. has developed a unique electrocautery device that improves the clinical outcomes of deep tissue biopsy procedures. The company is based in Lake Forest, CA. The patented, single-use device prevents and stops bleeding caused by tissue extraction by cauterizing the tissue channel. It is the only cautery device of its kind that can be used for biopsy procedures. Singlepass was founded by Peter Sunenshine and Kevin Hirsch. The CEO is Bill Colone. | Health Technology |
- Börse
- Insiders
- Bill Colone
- Erfahrung